Literature DB >> 3682156

Change in public perspective on cholesterol and heart disease. Results from two national surveys.

B Schucker1, K Bailey, J T Heimbach, M E Mattson, J T Wittes, C M Haines, D J Gordon, J A Cutler, V S Keating, R S Goor.   

Abstract

The National Heart, Lung and Blood Institute, Bethesda, Md, and the Food and Drug Administration, Washington, DC, sponsored two national probability telephone surveys (N = 4000) of adults to assess attitudes and knowledge about heart disease risk from high blood cholesterol levels and the public's efforts to lower blood cholesterol levels. The first survey was conducted in 1983, before release of the results from the Lipid Research Clinics Coronary Primary Prevention Trial, which showed that a reduction in the blood cholesterol level reduced coronary heart disease; the second survey was conducted in 1986. The percentage of adults who believed that reducing high blood cholesterol levels would have a large effect on heart disease increased from 64% in 1983 to 72% in 1986, so that the importance attached to reducing high blood cholesterol levels approached that attributed to reducing smoking and high blood pressure. In 1983, 35% of adults reported that they had their cholesterol level checked vs 46% in 1986. In both years, diet changes were most frequently chosen (greater than 60%) as ways to control the blood cholesterol level; reducing dietary fat was believed to be as important as reducing dietary cholesterol. By 1986, 23% of adults reported that they made dietary changes specifically to lower their blood cholesterol level, up from 14% in 1983. These comparative data show gains in public awareness and action relating to high blood cholesterol level risk. The data can be used to develop education programs.

Entities:  

Mesh:

Year:  1987        PMID: 3682156

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Knowledge of nutrition and coronary heart disease in Riyadh, Saudi Arabia.

Authors:  I A Bani; T J Hashim
Journal:  J Community Health       Date:  1999-12

2.  Knowledge and attitudes towards hypertension and hypercholesterolemia in a population of southern Germany: results from a population survey in the Augsburg area.

Authors:  S K Weiland; U Keil; A Spelsberg
Journal:  Soz Praventivmed       Date:  1991

Review 3.  Mass media approaches to reducing cardiovascular disease risk.

Authors:  T Bellicha; J McGrath
Journal:  Public Health Rep       Date:  1990 May-Jun       Impact factor: 2.792

4.  Awareness and use of blood cholesterol tests in 40-74-year-olds by educational level.

Authors:  A P Polednak
Journal:  Public Health Rep       Date:  1992 May-Jun       Impact factor: 2.792

5.  Cardiovascular risk modification in the college student: knowledge, attitudes, and behaviors.

Authors:  R Frost
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

6.  Are people more health conscious? A longitudinal study of one community.

Authors:  M Niknian; R C Lefebvre; R A Carleton
Journal:  Am J Public Health       Date:  1991-02       Impact factor: 9.308

7.  Cholesterol: controversy and confusion.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1990-04       Impact factor: 3.275

8.  Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies.

Authors:  Roberta E Goldman; Donna R Parker; Charles B Eaton; Jeffrey M Borkan; Robert Gramling; Rebecca T Cover; David K Ahern
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

Review 9.  Risk factors for coronary heart disease. Selected recent epidemiological advances.

Authors:  S B Hulley
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.

Authors:  John Z Ayanian; Bruce E Landon; Mary Beth Landrum; James R Grana; Barbara J McNeil
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.